Abstract: An electrode sheet drying equipment, an electrode sheet manufacturing system including the same, and an electrode sheet drying method including an air-floating roller disposed downstream of a drying oven, and the air-floating roller is configured to spray hot air through multiple air spraying holes formed on the outer circumferential surface. Accordingly, the electrode sheet discharged from the drying oven in a partially undried state can be additionally dried, thereby preventing contamination of a transfer roller and/or equipment of the subsequent process.

Abstract: An infrared heat source module is configured to minimize problems such as wrinkles or cracks in electrodes even if the patterns of a coated part and an uncoated part of the electrodes present in a current collector vary. The module improves a drying efficiency of the coated part of the current collector. An electrode using the infrared heat source module is manufactured by a process.

Abstract: An electrode manufacturing apparatus includes a supply part to supply an electrode precursor, a drying part to dry the electrode slurry, an air supply part to supply high-temperature vapor, an air introducing part to introduce the supplied high-temperature vapor, a flow path connected from the air introducing part to the air supply part, a sensor to measure humidity, an air discharge part, and a humidifying part to humidify the high-temperature vapor. The apparatus further includes a discharge part to discharge the manufactured electrode, a monitoring part, and a control part to collect monitoring information and information on the humidity to control whether to open or close the air discharge part and a degree of humidification by the humidifying part. An electrode manufacturing method using the apparatus thereof.

Abstract: Novel compounds exhibiting good inhibitory activity versus Dipeptidyl Peptidase-IV(DPP-IV) include those of the following formula (1) or pharmaceutically acceptable salt thereof: wherein A is a substituted or unsubstituted 1,4,5,7-tetrahydro-pyrazolo[3,4-c]pyridine, 5,6 -dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazine, 4,5-dihydro-7H-isooxazolo[3,4-c]pyridine, 3,4 -dihydroisoquinoline, 5,8-dihydropyrido[3,4-d]pyrimidine, or 6,7 -dihydro[1,3]thiazolo[4,5,c]pyridine, and B is a substituted or unsubstituted piperidin-2-one, morpholin-3-one, oxazolidin-2-one, pyrrolidin-2-one, or 1,5-dihydro-pyrrol-2-one. Methods of preparing the novel inhibitory compounds of formula (1) and pharmaceutical compositions containing the same as an active agent are disclosed.

Abstract: The present invention relates to novel compounds exhibiting good inhibitory activity versus Dipeptidyl Peptidase-IV (DPP-IV), methods of preparing the same and pharmaceutical compositions containing the same as an active agent.

Abstract: The present invention relates to a compound with aryl-amidines, particularly amidinoaryl-cyclopropanes, amidinoarylmethyl-pyrroles, amidinoaryl-benzenes, amidinoaryl-pyridines, or amindonoaryl-alanines, represented by formula (1), a pharmaceutically acceptable salt, a prodrug, a hydrate, a solvate or an isomer thereof, which are inhibitors of coagulation enzyme, factor Xa (FXa). The present invention also relates to a pharmaceutical composition containing the compound, and a method of using the same as an anticoagulant agent for treatment and prevention of thrombosis disorders.